Delivery Order SPE2DB20D3304-SPE2DB25FW7K8
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lisdexamfetamine 40 mg capsules (100 count) valued at $1,426.80 under a firm fixed-price contract structure. The award was made on August 20, 2025, with an ultimate completion date of August 21, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,089.66 to AmerisourceBergen Drug Corp for Lisdexamfetamine 40 mg capsules (100-count units). The contract is classified as a firm fixed-price delivery order with an ultimate completion date of August 18, 2025. This award was made through open competition with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lisdexamfetamine 40 mg capsules (90-count) on October 21, 2025, with an ultimate completion date of October 22, 2025. This firm fixed-price delivery order carries a ceiling value of $1,067.41 and represents a non-competitive set-aside contract. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100-count units) under a firm fixed-price contract with a ceiling value of $1,137.22. This non-set-aside delivery order is scheduled for ultimate completion on August 19, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100-count) with a ceiling value of $1,246.23. This is a firm fixed-price delivery order issued under a non-set-aside competitive procurement, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania, and an ultimate completion date of September 18, 2025. The award represents a standard pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $1,240.57 to AmerisourceBergen Drug Corp for 100 capsules of Lisdexamfetamine 40 mg, a Schedule II controlled substance commonly prescribed for attention-deficit/hyperactivity disorder. The contract was competitively awarded on June 25, 2025, with an ultimate completion date of June 26, 2025, and is classified as a firm fixed-price delivery order with no set-aside designation. Performance will occur at AmerisourceBergen's...
- The Defense Logistics Agency awarded a $9,594.39 delivery order to AmerisourceBergen Drug Corp for Lisdexamfetamine 40 mg capsules (100-count units) on August 8, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 29, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100-count) with a ceiling value of $1,148.10. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 30, 2025, with performance to be fulfilled from the contractor's Conshohocken, Pennsylvania location. No set-aside designation was applied to this award. This delivery order is issued under...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,198.41 for Lisdexamfetamine 40 mg capsules (100 count) on July 28, 2025, with completion expected by July 29, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply agreement. The pharmaceutical product will be delivered to the company's distribution facility in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $1,831.50 to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 10 mg capsules (100-count units). The contract was executed as a firm fixed-price delivery order with an ultimate completion date of June 10, 2025, and represents a competitive award with no set-aside designation. Performance will be executed from the vendor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen...
- SPE2DB20D3304Indefinite Delivery Contract
- SPE2DB20D3304-SPE2DB25FW7K8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lisdexamfetamine 40 mg capsules (100 count) valued at $1,289.97 under a firm fixed-price contract type. The award was made on June 17, 2025, with an ultimate completion date of June 18, 2025, and represents a non-set-aside competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999,999,999.00 ceiling value extending through December 2026. This prime indefinite delivery vehicle supports global pharmaceutical supply needs across the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, encompassing a comprehensive range of medications, vaccines, medical devices, and specialized healthcare commodities. The pharmaceutical product being delivered under this order is a Schedule II controlled substance used in the treatment of attention deficit hyperactivity disorder, demonstrating AmerisourceBergen's role as a critical pharmaceutical distributor for military and veteran healthcare procurement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 6/17/25 |